Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
This study is currently recruiting participants.
Study NCT00663936   Information provided by Toyama Chemical Co., Ltd.
First Received: April 18, 2008   Last Updated: September 16, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alzheimer's Disease
Additional conditions recognized in this trial
Alzheimer Disease
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies
Interventions listed in this trial
T-817MA
Placebo
Sponsors listed in this trial
Toyama Chemical Co., Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services